Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Revenue: 2013-2025

Historic Revenue for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $17.6 million.

  • Fortress Biotech's Revenue rose 20.52% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $62.3 million, marking a year-over-year decrease of 0.32%. This contributed to the annual value of $57.7 million for FY2024, which is 31.76% down from last year.
  • As of Q3 2025, Fortress Biotech's Revenue stood at $17.6 million, which was up 7.42% from $16.4 million recorded in Q2 2025.
  • Fortress Biotech's 5-year Revenue high stood at $34.8 million for Q3 2023, and its period low was $11.6 million during Q1 2021.
  • Its 3-year average for Revenue is $17.2 million, with a median of $15.1 million in 2024.
  • As far as peak fluctuations go, Fortress Biotech's Revenue spiked by 122.53% in 2021, and later plummeted by 57.90% in 2024.
  • Over the past 5 years, Fortress Biotech's Revenue (Quarterly) stood at $18.3 million in 2021, then declined by 10.24% to $16.4 million in 2022, then climbed by 21.59% to $19.9 million in 2023, then dropped by 24.20% to $15.1 million in 2024, then climbed by 20.52% to $17.6 million in 2025.
  • Its Revenue stands at $17.6 million for Q3 2025, versus $16.4 million for Q2 2025 and $13.1 million for Q1 2025.